CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 8-K Event Other events
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 8-A12G Other 8-A12G
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10QSB Other 10QSB
- 8-K Event Other events
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- SB-2/A Other SB-2/A
- 8-K Event Other events
- 424B3 Offering Prospectus
Page 54 of 72 · 1,429 filings